News From Jarred Younger / Neuroinflammation, Pain, and Fatigue Laboratory at UAB, From Aug 2020

"043 - New paper published! Air quality affects pain and fatigue.

Here is our new paper on air quality and chronic pain and fatigue. Just click the download button at: https://www.mdpi.com/1660-4601/21/12/1560

The real-time air quality map I used for this presentation can be found at: https://www2.purpleair.com/ . You can click on one of the map links on that page.

Jarred Younger"

https://www.youtube.com/watch?v=wqoSZwUZ2EM

 

https://www.youtube.com/watch?v=sEZWC59eLkw

 

"045 - Can we filter ME/CFS and Long-COVID out of our blood (apheresis)?

Two new pilot studies indicate that therapeutic apheresis may be helpful in controlling ME/CFS and Long-COVID symptoms. The published report can be found at: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-2445-8593

Jarred Younger"

https://www.youtube.com/watch?v=-NSAdHFe7CU

 

046 - Does oxaloacetate reduce ME/CFS fatigue?

https://www.youtube.com/watch?v=8IMGWneBEsg

@6:40 He mentions using the Chalder Fatigue Scale uncritically, so this is not a study of PEM-ME.

 

"047 - Intranasal antihistamines may prevent Long-COVID

Here is the link to the open-access paper. You should be able to access it by clicking on the PDF button: https://pmc.ncbi.nlm.nih.gov/articles/PMC10388239/

- Jarred Younger"

https://www.youtube.com/watch?v=iRWY2ugEBbY

 

Has there been any updates on Younger's leukocyte tracking scan or his PET and MRI scans in ME/CFS patients? He mentioned the PET scan should be done in 2024 but it seems like its been a while since he's given any new info.

 

Here are the two ME/CFS neuroimaging studies out of his university that I can see. I think the first is the one you're asking about. Both still say "recruiting".

Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.
Primary/Study Completion (Estimated)
2028-10

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
Primary/Study Completion (Estimated)
2026-04-10